APA

Papaxoinis G., Kotoula V., Giannoulatou E., Koliou G., Karavasilis V., Lakis S., Koureas A., Bobos M., Chalaralambous E., Daskalaki E., Chatzopoulos K., Tsironis G., Pazarli E., Chrisafi S., Samantas E., Kaklamanos I. G., Varthalitis I., Konstantara A., Syrigos K. N., Pentheroudakis G., Pectasides D. & Fountzilas G. (20181127). Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. : Medical oncology (Northwood, London, England).

Chicago

Papaxoinis George, Kotoula Vassiliki, Giannoulatou Eleni, Koliou Georgia-Angeliki, Karavasilis Vasilios, Lakis Sotirios, Koureas Andreas, Bobos Mattheos, Chalaralambous Elpida, Daskalaki Emily, Chatzopoulos Kyriakos, Tsironis George, Pazarli Elisavet, Chrisafi Sofia, Samantas Epaminontas, Kaklamanos Ioannis G, Varthalitis Ioannis, Konstantara Athina, Syrigos Konstantinos N, Pentheroudakis George, Pectasides Dimitrios and Fountzilas George. 20181127. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. : Medical oncology (Northwood, London, England).

Harvard

Papaxoinis G., Kotoula V., Giannoulatou E., Koliou G., Karavasilis V., Lakis S., Koureas A., Bobos M., Chalaralambous E., Daskalaki E., Chatzopoulos K., Tsironis G., Pazarli E., Chrisafi S., Samantas E., Kaklamanos I. G., Varthalitis I., Konstantara A., Syrigos K. N., Pentheroudakis G., Pectasides D. and Fountzilas G. (20181127). Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. : Medical oncology (Northwood, London, England).

MLA

Papaxoinis George, Kotoula Vassiliki, Giannoulatou Eleni, Koliou Georgia-Angeliki, Karavasilis Vasilios, Lakis Sotirios, Koureas Andreas, Bobos Mattheos, Chalaralambous Elpida, Daskalaki Emily, Chatzopoulos Kyriakos, Tsironis George, Pazarli Elisavet, Chrisafi Sofia, Samantas Epaminontas, Kaklamanos Ioannis G, Varthalitis Ioannis, Konstantara Athina, Syrigos Konstantinos N, Pentheroudakis George, Pectasides Dimitrios and Fountzilas George. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. : Medical oncology (Northwood, London, England). 20181127.